EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Urinary Uremic Toxin Signatures and the Metabolic Index of Gut Dysfunction (MIGD) in Autism Spectrum Disorder: A Stool-Phenotype-Stratified Analysis

Joško Osredkar iD, Teja Fabjan, Kristina Kumer iD, Maja Jekovec-Vrhovšek, Joanna Giebułtowicz iD, Barbara Bobrowska-Korczak iD, Gorazd Avguštin iD, Uroš Godnov iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Joško Osredkar und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Zaloška cesta 2, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Feces, Uremic Toxins. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Slovenian Research and Innovation Agency, Slovenian Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut-derived uremic toxins may play a key role in neurodevelopmental conditions such as autism spectrum disorder (ASD) via host-microbe metabolic interactions. We evaluated five uremic toxins—p-cresyl sulfate (PCS), indoxyl sulfate (IS), trimethylamine N-oxide (TMAO), asymmetric dimethylarginine (ADMA), and symmetric dimethylarginine (SDMA)—in urine samples of 97 children with ASD and 71 neurotypical controls, stratified by Bristol Stool Chart (BSC) consistency types. Four of these toxins (PCS, IS, TMAO, ADMA) were integrated into a novel composite biomarker called the Metabolic Index of Gut Dysfunction (MIGD), while SDMA was measured as a complementary renal function marker. While individual metabolite levels showed no statistically significant differences, group-wise analysis by stool phenotype revealed distinct trends. ASD children with hard stools (BSC 1–2) showed elevated PCS levels and the MIGD score (median 555.3), reflecting phenolic fermentation dominance with reduced indolic detoxification. In contrast, children with loose stools (BSC 6–7) had the lowest MIGD values (median 109.8), driven by higher IS and lower ADMA concentrations, suggestive of enhanced indole metabolism. These findings indicate that MIGD may serve as a novel biomarker to stratify metabolic phenotypes in ASD, linking urinary metabolite patterns to gut function. Further validation in larger and longitudinal cohorts is warranted to confirm its potential utility in precision microbiota-targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderFecesUremic ToxinsHumansMaleChildFemaleBiomarkersChild, PreschoolArgininePhenotypeGastrointestinal MicrobiomeIndicanCase-Control StudiesMethylaminesSulfuric Acid EstersCresols

Stichwörter der Autor:innen

Bristol Stool Chartautism spectrum disordergut metabolic dysfunctionindoxyl sulfatemicrobiota–host interactionsp-cresyl sulfateuremic toxinsurinary biomarkers

Substanzen

BiomarkersUremic ToxinsArgininetrimethyloxamineIndican4-cresol sulfateMethylaminesSulfuric Acid EstersCresols

Autor:innen und Institutionen

  • Institute of Clinical Chemistry and Biochemistry, University Medical Centre Ljubljana, Zaloška cesta 2, 1000 Ljubljana, Slovenia.
  • Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.
  • Center for Autism, Unit of Child Psychiatry, University Children's Hospital, University Medical Centre Ljubljana, 1000 Ljubljana, Slovenia.
  • Department of Bioanalysis and Drug Analysis, Faculty of Pharmacy with the Laboratory Medicine Division, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.
  • Department of Toxicology and Food Science, Faculty of Pharmacy with the Laboratory Medicine Division, Medical University of Warsaw, Banacha 1, 02-097 Warsaw, Poland.
  • Department of Microbiology, Biotechnical Faculty, University of Ljubljana, Groblje 3, 1230 Domžale, Slovenia.

ORCID-Profile: Joško Osredkar, Kristina Kumer, Joanna Giebułtowicz, Barbara Bobrowska-Korczak, Gorazd Avguštin, Uroš Godnov

Förderung

  • The Slovenian Research and Innovation Agency
  • Slovenian Research Agency

Zitieren

APA

Osredkar, J., Fabjan, T., Kumer, K., Jekovec-Vrhovšek, M., Giebułtowicz, J., Bobrowska-Korczak, B., Avguštin, G., & Godnov, U. (2025). Urinary Uremic Toxin Signatures and the Metabolic Index of Gut Dysfunction (MIGD) in Autism Spectrum Disorder: A Stool-Phenotype-Stratified Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110475

Vancouver

Osredkar J, Fabjan T, Kumer K, Jekovec-Vrhovšek M, Giebułtowicz J, Bobrowska-Korczak B, et al. Urinary Uremic Toxin Signatures and the Metabolic Index of Gut Dysfunction (MIGD) in Autism Spectrum Disorder: A Stool-Phenotype-Stratified Analysis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110475

BibTeX
@article{Osredkar2025,
  author = {Osredkar, Joško and Fabjan, Teja and Kumer, Kristina and Jekovec-Vrhovšek, Maja and Giebułtowicz, Joanna and Bobrowska-Korczak, Barbara and Avguštin, Gorazd and Godnov, Uroš},
  title = {Urinary Uremic Toxin Signatures and the Metabolic Index of Gut Dysfunction (MIGD) in Autism Spectrum Disorder: A Stool-Phenotype-Stratified Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110475}
}
Kostenlos starten →